Charles Perou

74PUBLICATIONS
564CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Bioinformatic methods developmentWomen's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (74)

|Aug 17, 2026
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable antitumor immunity in triple negative breast cancer.

|Aug 14, 2026
Transcriptomic Profiling of Mouse Mammary Tumors Enables Prognostic and Predictive Biomarker Discovery for Human Breast Cancer.

|Jul 28, 2026
Kinase Plasticity with Vandetanib Treatment Enhances Sensitivity to Tamoxifen in Estrogen Receptor Positive Breast Cancer.

|May 13, 2026
Single-Cell Transcriptomics Reveals Immune Landscape Dynamics in Metastatic Hormone Receptor-Positive Breast Cancer Treated with Abemaciclib and Endocrine Therapy.

|Mar 26, 2026
Integrated Multiomic Profiling Identifies BRD8/EP400 as a Pivotal Chromatin Module Mediating Anti-HER2 Response in HR+/HER2+ Breast Cancer.

Ang Gao, Parth H Khatri, Gui Ma

|Mar 16, 2026
Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancers.

Matthew D Sutcliffe, Kevin R Mott, Tulay Yilmaz-Swenson

Pageof 13

Frequent Collaborators

15 joint publications

Katherine A Hoadley

12 joint publications

Joel S Parker

12 joint publications

Lisa A Carey

6 joint publications

Adam D Pfefferle